In Vitro Culture, Drug Sensitivity, and Transcriptome of Plasmodium Vivax Hypnozoites.

Cell Host & Microbe
Nil GuralSangeeta N Bhatia

Abstract

The unique relapsing nature of Plasmodium vivax infection is a major barrier to malaria eradication. Upon infection, dormant liver-stage forms, hypnozoites, linger for weeks to months and then relapse to cause recurrent blood-stage infection. Very little is known about hypnozoite biology; definitive biomarkers are lacking and in vitro platforms that support phenotypic studies are needed. Here, we recapitulate the entire liver stage of P. vivax in vitro, using a multiwell format that incorporates micropatterned primary human hepatocyte co-cultures (MPCCs). MPCCs feature key aspects of P. vivax biology, including establishment of persistent small forms and growing schizonts, merosome release, and subsequent infection of reticulocytes. We find that the small forms exhibit previously described hallmarks of hypnozoites, and we pilot MPCCs as a tool for testing candidate anti-hypnozoite drugs. Finally, we employ a hybrid capture strategy and RNA sequencing to describe the hypnozoite transcriptome and gain insight into its biology.

Citations

May 17, 2019·ELife·Devendra Kumar GuptaThierry Tidiane Diagana
Aug 24, 2018·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Gregory H Underhill, Salman R Khetani
Jun 21, 2019·Briefings in Functional Genomics·Christa G Toenhake, Richárd Bártfai
Aug 25, 2019·Nature Reviews. Microbiology·Michael P BarrettRick L Tarleton
Sep 26, 2019·Malaria Journal·Reto CaldelariVolker Heussler
Apr 10, 2019·Pathogens·Myriam D JeningaMichaela Petter
Jun 27, 2019·Briefings in Functional Genomics·Mary R Galinski
Nov 28, 2018·Parasitology Research·Rahul PasupureddyKailash C Pandey
Jan 2, 2020·APL Bioengineering·Gregory H Underhill, Salman R Khetani
Feb 6, 2020·MBio·Maria Toro-MorenoEmily R Derbyshire
Aug 2, 2019·Clinical Microbiology Reviews·J Kevin Baird
Oct 21, 2020·Antimicrobial Agents and Chemotherapy·Laurent DembéléGeorges Snounou
Feb 16, 2021·Frontiers in Cellular and Infection Microbiology·Annemarie Voorberg-van der WelAnne-Marie Zeeman
Feb 16, 2021·Frontiers in Cellular and Infection Microbiology·Sylvie BriquetCatherine Vaquero
Feb 3, 2021·International Journal for Parasitology. Drugs and Drug Resistance·Jean PopoviciDavid Serre
Dec 2, 2020·Trends in Parasitology·Catherine J Merrick
Apr 25, 2020·Cell Chemical Biology·Dora PosfaiEmily R Derbyshire
Mar 22, 2021·Malaria Journal·Nicholas J White
Jun 14, 2019·Biomaterials·Adeline C Y ChuaPablo Bifani
Jul 2, 2021·Frontiers in Cellular and Infection Microbiology·Kayla SylvesterEmily R Derbyshire
Jun 15, 2021·Bio-protocol·Annemarie Voorberg-van der WelClemens H M Kocken
Jul 2, 2021·Nature·Agnes Mwakingwe-OmariPatrick E Duffy
Jul 22, 2021·APL Bioengineering·Chase P MoncktonSalman R Khetani
Apr 9, 2020·Analytical Chemistry·Annemarie M Voorberg-van der WelClemens H M Kocken
Sep 3, 2021·Parasitology International·Gigliola Zanghi, Ashley M Vaughan
Jul 2, 2021·Annual Review of Microbiology·Carola SchäferStefan H I Kappe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.